Independent urology faces stagnant Medicare pay, rising costs, prior auth burden, and consolidation pressure, Celeste Kirschner, CAE, MHSA, says.
|Articles|December 1, 2004
Medicare revenue for urologists will drop 14% in 2005
Washington--The Centers for Medicare & Medicaid Services has published its final rule implementing the 2005 Medicare fee schedule, and it's not good news for urologists-especially those who administer cancer drugs in their offices.
Advertisement
Advertisement
Related to this article
LUGPA CEO Celeste Kirschner, CAE, MHSA, outlines the association's top 2027 priorities: fee schedule reform, site-neutral payments, prior authorization, and practice consolidation.
Advertisement
Advertisement
Trending on Urology Times
1
CHMP recommends perioperative enfortumab vedotin plus pembrolizumab for MIBC
2
Topical sildenafil cream associated with lower systemic exposure vs oral sildenafil
3
FAQs: The 2026 AUA Guideline on Medical Management of Kidney Stones
4
The UroOnc Minute: Neoadjuvant Therapy Before Radical Prostatectomy, With Isaac Y. Kim, MD, PhD, MBA
5